|
1
|
Sen R and Baltimore D: Multiple nuclear
factors interact with the immunoglobulin enhancer sequences. Cell.
46:705–716. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zandi E and Karin M: Bridging the gap:
composition, regulation, and physiological function of the IkappaB
kinase complex. Mol Cell Biol. 19:4547–4551. 1999.PubMed/NCBI
|
|
3
|
Baldwin AS: Control of oncogenesis and
cancer therapy resistance by the transcription factor NF-kappaB. J
Clin Invest. 3:241–246. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gottesman MM, Fojo T and Bates SE:
Multidrug resistance in cancer: role of ATP-dependent transporters.
Nat Rev Cancer. 2:48–58. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang CY, Guttridge DC, Mayo MW and Baldwin
AS Jr: NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1
to preferentially suppress chemotherapy-induced apoptosis. Mol Cell
Biol. 19:5923–5929. 1999.PubMed/NCBI
|
|
6
|
Wang CY, Mayo MW, Korneluk RG, Goeddel DV
and Baldwin AS Jr: NF-kappaB antiapoptosis: induction of TRAF1 and
TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation.
Science. 281:1680–1683. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Karin M: Nuclear factor-kappaB in cancer
development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mitsiades N, Mitsiades CS, Poulaki V,
Anderson KC and Treon SP: Intracellular regulation of tumor
necrosis factor-related apoptosis-inducing ligand-induced apoptosis
in human multiple myeloma cells. Blood. 99:2162–2171. 2002.
View Article : Google Scholar
|
|
9
|
Poynter JN, Haile RW, Siegmund KD,
Campbell PT, Figueiredo JC, Limburg P, Young J, Le Marchand L,
Potter JD, Cotterchio M, Casey G, Hopper JL, Jenkins MA, Thibodeau
SN, Newcomb PA and Baron JA; Colon Cancer Family Registry:
Associations between smoking, alcohol consumption, and colorectal
cancer, overall and by tumor microsatellite instability status.
Cancer Epidemiol Biomarkers Prev. 18:2745–2750. 2009. View Article : Google Scholar
|
|
10
|
Bostick RM, Potter JD, Kushi LH, Sellers
TA, Steinmetz KA, McKenzie DR, Gapstur SM and Folsom AR: Sugar,
meat and fat intake, and non-dietary risk factors for colon cancer
incidence in Iowa women. Cancer Causes Control. 5:38–52. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chan AT and Giovannucci EL: Primary
prevention of colorectal cancer. Gastroenterology. 138:2029–2043.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim HJ, Hawke N and Baldwin AS: NF-kappaB
and IKK as therapeutic targets in cancer. Cell Death Differ.
13:738–747. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Legrand-Poels S, Schoonbroodt S, Matroule
JY and Piette J: NF-kappaB: an important transcription factor in
photobiology. Photochem Photobiol B. 45:1–8. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Romano MF, Lamberti A, Bisogni R, Tassone
P, Pagnini D, Storti G, Del Vecchio L, Turco MC and Venuta S:
Enhancement of cytosine arabinoside induced apoptosis in human
myeloblastic leukemia cells by NF kappaB/Rel-specific decoy
oligodeoxy-nucleotides. Gene Ther. 7:1234–1237. 2000. View Article : Google Scholar
|
|
15
|
Beg AA, Sha WC, Bronson RT, Ghosh S and
Baltimore D: Embryonic lethality and liver degeneration in mice
lacking the RelA component of NF-kappaB. Nature. 376:167–170. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Holmes-McNary M and Baldwin AS Jr:
Chemopreventive properties of trans-resveratrol are associated with
inhibition of activation of IkappaB kinase. Cancer Res.
60:3477–3483. 2000.PubMed/NCBI
|
|
17
|
Yemelyanov A, Gasparian A, Lindholm P,
Dang L, Pierce JW, Kisseljov F, Karseladze A and Budunova I:
Effects of IKK inhibitor PS1145 on NF-kappaB function,
proliferation, apoptosis and invasion activity in prostate
carcinoma cells. Oncogene. 25:387–398. 2006.PubMed/NCBI
|
|
18
|
Wu LF, Li GP, Su JD, Pu ZJ, Feng JL, Ye YQ
and Wei BL: Involvement of NF-kappaB activation in the apoptosis
induced by extracellular adenosine in human hepatocellular
carcinoma HepG2 cells. Biochem Cell Biol. 88:705–714.
2010.PubMed/NCBI
|
|
19
|
Furuta H, Osawa K, Shin M, Ishikawa A,
Matsuo K, Khan M, Aoki K, Ohya K, Okamoto M, Tominaga K, et al:
Selective inhibition of NF-κB suppresses bone invasion by oral
squamous cell carcinoma in vivo. Int J Cancer. Jan 19–2012.(Epub
ahead of print).
|
|
20
|
Zhu BS, Xing CG, Lin F, Fan XQ, Zhao K and
Qin ZH: Blocking NF-κB nuclear translocation leads to p53-related
autophagy activation and cell apoptosis. World J Gastroenterol.
17:478–487. 2011.
|
|
21
|
Si X, McManus BM, Zhang JC, Yuan J, Cheung
C, Esfandiarei M, Suarez A, Morgan A and Luo HL: Pyrrolidine
dithiocarbamate reduces coxsackievirus B3 replication through
inhibition of the ubiquitin-proteasome pathway. J Virol.
79:8014–8023. 2005. View Article : Google Scholar
|
|
22
|
Caravita T, de Fabritiis P, Palumbo A,
Amadori S and Boccadoro M: Bortezomib: efficacy comparisons in
solid tumors and hematologic malignancies. Nat Clin Pract Oncol.
3:374–387. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nencioni A, Grünebach F, Patrone F,
Ballestrero A and Brossart P: Proteasome inhibitors: antitumor
effects and beyond. Leukemia. 21:30–36. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Orange JS and May MJ: Cell penetrating
peptide inhibitors of nuclear factor-kappaB. Cell Mol Life Sci.
65:3564–3591. 2008. View Article : Google Scholar : PubMed/NCBI
|
